Concepedia

Laura Cons

LC

Statistics

Publications

10

Citations

701

H-Index

10

Active since

2013

Affiliations

Light Chain Bioscience (Switzerland)(Current)

University of Geneva

Laura Cons is an author at Light Chain Bioscience (Switzerland) specializing in immunology, cancer immunotherapy, and oncology.

Publications per year

2013–2023

10

Publications

10

GlycoDelete engineering of mammalian cells simplifies N-glycosylation of recombinant proteins

Leander Meuris, Francis Santens, Greg Elson et al. · Nature Biotechnology · 2014 · 149 citations · Full text

, , +15

Selective Blockade of the Ubiquitous Checkpoint Receptor CD47 Is Enabled by Dual-Targeting Bispecific Antibodies

Elie Dheilly, Valéry Moine, Lucile Broyer et al. · Molecular Therapy · 2017 · 142 citations · Full text

, , +17

Exploiting light chains for the scalable generation and platform purification of native human bispecific IgG

Nicolas Fischer, Greg Elson, Giovanni Magistrelli et al. · Nature Communications · 2015 · 119 citations · Full text

, , +17

Preclinical Development of a Bispecific Antibody that Safely and Effectively Targets CD19 and CD47 for the Treatment of B-Cell Lymphoma and Leukemia

Vanessa Buatois, Zoë Johnson, Susana Salgado-Pires et al. · Molecular Cancer Therapeutics · 2018 · 114 citations · Full text

, , +17

Use of a mouse model to identify a blood biomarker for IFNγ activity in pediatric secondary hemophagocytic lymphohistiocytosis

Vanessa Buatois, Laurence Chatel, Laura Cons et al. · Translational research · 2016 · 61 citations · Full text

, , +17

1–5 of 10